67457-615-20 : NDC 2026 Code

67457-615-20 : Cytarabine ( Cytarabine )

Additionally :

You can get information about “67457-615-20” NDC code in 67457-615-20 in HTML format

HTML | 67457-615-20 in TXT (Plain Text) format

TXT | 67457-615-20 in PDF (Portable Document Format)

PDF | 67457-615-20 in XML format

XML formats.

NDC Code : 67457-615-20 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "67457-615-20",
    "PackageDescription": "1 VIAL in 1 CARTON (67457-615-20)  &gt; 20 mL in 1 VIAL",
    "NDC11Code": "67457-0615-20",
    "ProductNDC": "67457-615",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Cytarabine",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Cytarabine",
    "DosageFormName": "INJECTION",
    "RouteName": "INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS",
    "StartMarketingDate": "20120131",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA201784",
    "LabelerName": "Mylan Institutional LLC",
    "SubstanceName": "CYTARABINE",
    "StrengthNumber": "2",
    "StrengthUnit": "g/20mL",
    "Pharm_Classes": "Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2019-02-16",
    "PackageNdcExcludeFlag": null,
    "ProductNdcExcludeFlag": "E",
    "ListingRecordCertifiedThrough": "20171231",
    "StartMarketingDatePackage": null,
    "EndMarketingDatePackage": null,
    "SamplePackage": null
  }
}